Viewing Study NCT01676558


Ignite Creation Date: 2025-12-25 @ 12:09 AM
Ignite Modification Date: 2026-01-01 @ 1:22 PM
Study NCT ID: NCT01676558
Status: UNKNOWN
Last Update Posted: 2012-11-14
First Post: 2012-08-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase II Study of 131I-rituximab for Relapsed/Refractory Diffuse Large B Cell Lymphoma (DLBCL)
Sponsor: Korea Cancer Center Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module